MAYZENT®
Indications

Mayzent is indicated for the treatment of adult patients with secondary progressive multiple sclerosis (SPMS) with active disease evidenced by relapses or imaging features of inflammatory activity.

MAYZENT®

Package Insert

Rate this content: 
0
No votes yet
SG2311060355, FA-11236876, FA-11236884
×

Medical Information Request

×

Ask Speakers